From: Henrik Søren Larsen Sent: 7 May 2015 10:55:43 +0200 To: Michel Schilling;Yvonne Korup Subject: Fra ENS ti
![PDF) Comparative effectiveness and safety of non-Vitamin K antagonist oral anticoagulants and warfarin in patients with Atrial fibrillation: Propensity weighted nationwide cohort study PDF) Comparative effectiveness and safety of non-Vitamin K antagonist oral anticoagulants and warfarin in patients with Atrial fibrillation: Propensity weighted nationwide cohort study](https://i1.rgstatic.net/publication/304028590_Comparative_effectiveness_and_safety_of_non-Vitamin_K_antagonist_oral_anticoagulants_and_warfarin_in_patients_with_Atrial_fibrillation_Propensity_weighted_nationwide_cohort_study/links/5a19a91d4585155c26ac524b/largepreview.png)
PDF) Comparative effectiveness and safety of non-Vitamin K antagonist oral anticoagulants and warfarin in patients with Atrial fibrillation: Propensity weighted nationwide cohort study
![PDF) Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage PDF) Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage](https://i1.rgstatic.net/publication/331762518_Non-Vitamin_K_Antagonist_Oral_Anticoagulants_Versus_Warfarin_in_Atrial_Fibrillation_Patients_With_Intracerebral_Hemorrhage/links/5c8b0a91a6fdcc38175421cd/largepreview.png)